Literature DB >> 21816706

Survivorship care guidelines for patients living with multiple myeloma: consensus statements of the International Myeloma Foundation Nurse Leadership Board.

Elizabeth Bilotti1, Beth M Faiman, Tiffany A Richards, Joseph D Tariman, Teresa S Miceli, Sandra I Rome.   

Abstract

Novel therapies approved over the past decade for the management of multiple myeloma have contributed to improved overall survival in patients with newly diagnosed and relapsed disease. Nurses play a key role in educating, advocating for, and supporting patients throughout the continuum of care. Identifying potential and actual comorbid conditions associated directly with multiple myeloma and its treatment is important, as is confirming those that are patient specific so that prompt intervention can take place; therefore, the International Myeloma Foundation Nurse Leadership Board identified the most significant needs of patients diagnosed with multiple myeloma as bone health, health maintenance, mobility and safety, sexual dysfunction, and renal health. The Nurse Leadership Board then developed a survivorship care plan to assist healthcare providers and patients with multiple myeloma, their partners, and their caregivers to identify these needs.

Entities:  

Mesh:

Year:  2011        PMID: 21816706      PMCID: PMC3422736          DOI: 10.1188/11.S1.CJON.5-8

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  4 in total

1.  Female sexual desire--beyond testosterone.

Authors:  Patricia A Ganz; Gail A Greendale
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

Review 2.  Treatment of myeloma: cure vs control.

Authors:  S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

3.  Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.

Authors:  Page Bertolotti; Elizabeth Bilotti; Kathleen Colson; Kathleen Curran; Deborah Doss; Beth Faiman; Maria Gavino; Bonnie Jenkins; Kathy Lilleby; Ginger Love; Patricia A Mangan; Emily McCullagh; Teresa Miceli; Kena Miller; Kathryn Rogers; Sandra Rome; Stacey Sandifer; Lisa C Smith; Joseph D Tariman; Jeanne Westphal
Journal:  Clin J Oncol Nurs       Date:  2008-06       Impact factor: 1.027

4.  Improved survival in multiple myeloma and the impact of novel therapies.

Authors:  Shaji K Kumar; S Vincent Rajkumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Steven R Zeldenrust; David Dingli; Stephen J Russell; John A Lust; Philip R Greipp; Robert A Kyle; Morie A Gertz
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

  4 in total
  6 in total

1.  Effects of comprehensive care in patients with multiple myeloma with cardiac dysfunction.

Authors:  Jinglu Xu; Ru Bai
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 2.  Nuances in the Management of Older People With Multiple Myeloma.

Authors:  Charlotte Pawlyn; Francesca Gay; Alessandra Larocca; Vivek Roy; Sikander Ailawadhi
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

3.  Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma.

Authors:  Shehzad Niazi; Ryan D Frank; Mayank Sharma; Vivek Roy; Steve Ames; Teresa Rummans; Aaron Spaulding; Taimur Sher; Meghna Ailawadhi; Kirtipal Bhatia; Salman Ahmed; Winston Tan; Asher Chanan-Khan; Sikander Ailawadhi
Journal:  Blood Adv       Date:  2018-05-22

4.  Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument.

Authors:  Sarah A Birken; Shellie D Ellis; Jennifer S Walker; Lisa D DiMartino; Devon K Check; Adrian A Gerstel; Deborah K Mayer
Journal:  Implement Sci       Date:  2015-05-03       Impact factor: 7.327

5.  Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients.

Authors:  A S Rosenberg; A Brunson; J Tuscano; B A Jonas; R Hoeg; T Wun; T H M Keegan
Journal:  Blood Cancer J       Date:  2021-01-07       Impact factor: 11.037

Review 6.  Treatment-related symptom management in patients with multiple myeloma: a review.

Authors:  Kathleen Colson
Journal:  Support Care Cancer       Date:  2015-02-03       Impact factor: 3.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.